Literature DB >> 18716604

Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension.

Melissa A Cadnapaphornchai1, Kim McFann, John D Strain, Amirali Masoumi, Robert W Schrier.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary condition that may be diagnosed in utero. Our goal was to evaluate symptoms of ADPKD in children, including left ventricular mass index (LVMI), renal volume, renal function and microalbuminuria in relation to systolic and diastolic blood pressure. Eighty-five children were stratified by blood pressure into three cohorts: hypertensive (95th percentile and over), borderline hypertensive (75-95th percentile) and normotensive (75th percentile and below). There were no differences in gender, age, height, renal function, or microalbuminuria between the groups. Both the hypertensive and borderline hypertensive children had a significantly higher LVMI than normotensive children, with no significant difference between hypertensive and borderline hypertensive groups. There was a significant correlation between renal volume and both systolic and diastolic blood pressures in all subjects. Renal volume in hypertensive children was significantly larger than in the borderline hypertensive group, with no significant difference between normotensive and borderline hypertensive groups. These findings show that an increase in LVMI may be detected earlier than an increase in renal volume in children with ADPKD and borderline hypertension, suggesting that close monitoring of cardiac status is indicated in these children.

Entities:  

Mesh:

Year:  2008        PMID: 18716604      PMCID: PMC2574635          DOI: 10.1038/ki.2008.397

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

2.  Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).

Authors:  W Charles O'Neill; Michelle L Robbin; Kyongtae T Bae; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Vicente E Torres; Bernard F King; Louis H Wetzel; Paul A Thompson; J Philip Miller
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

3.  Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.

Authors:  T Ecder; A B Chapman; G M Brosnahan; C L Edelstein; A M Johnson; R W Schrier
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

4.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

5.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Authors:  Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'Neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Philip Miller
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

6.  Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant.

Authors:  D H Pretorius; M E Lee; M L Manco-Johnson; G R Weingast; A B Sedman; P A Gabow
Journal:  J Ultrasound Med       Date:  1987-05       Impact factor: 2.153

7.  Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.

Authors:  Robert Schrier; Kimberly McFann; Ann Johnson; Arlene Chapman; Charles Edelstein; Godela Brosnahan; Tevfik Ecder; Lyn Tison
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

8.  Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease.

Authors:  Hubert Wong; Laura Vivian; Gabrielle Weiler; Guido Filler
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

9.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  P E Bell; K F Hossack; P A Gabow; J A Durr; A M Johnson; R W Schrier
Journal:  Kidney Int       Date:  1988-11       Impact factor: 10.612

10.  Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.

Authors:  Tomás Seeman; Jirí Dusek; Hana Vondrichová; Martin Kyncl; Ulrike John; Joachim Misselwitz; Jan Janda
Journal:  Blood Press Monit       Date:  2003-06       Impact factor: 1.444

View more
  46 in total

1.  Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways.

Authors:  Ivana Y Kuo; Andrea T Kwaczala; Lily Nguyen; Kerry S Russell; Stuart G Campbell; Barbara E Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

3.  Polycystin-1 Assembles With Kv Channels to Govern Cardiomyocyte Repolarization and Contractility.

Authors:  Francisco Altamirano; Gabriele G Schiattarella; Kristin M French; Soo Young Kim; Felipe Engelberger; Sergii Kyrychenko; Elisa Villalobos; Dan Tong; Jay W Schneider; Cesar A Ramirez-Sarmiento; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2019-06-21       Impact factor: 29.690

Review 4.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

Review 5.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

6.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

7.  Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms.

Authors:  Djalila Mekahli; Adrian S Woolf; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2010-08-05       Impact factor: 3.714

8.  Decade in review--polycystic kidney disease: Slowing progression of autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2015-10-13       Impact factor: 28.314

9.  Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Pamela Mettler; Kim Mc Fann; Oleksandra Tkachenko; Xiang-Dong Yan; Robert W Schrier
Journal:  Am J Nephrol       Date:  2012-10-04       Impact factor: 3.754

Review 10.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.